These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Phenylacetic acids and the structurally related non-steroidal anti-inflammatory drug diclofenac bind to specific gamma-hydroxybutyric acid sites in rat brain. Wellendorph P; Høg S; Skonberg C; Bräuner-Osborne H Fundam Clin Pharmacol; 2009 Apr; 23(2):207-13. PubMed ID: 19645815 [TBL] [Abstract][Full Text] [Related]
5. Ethanol does not alter the binding of the gamma-hydroxybutyric acid (GHB) receptor ligand [3H]NCS-382 in the rat brain. Mehta AK; Muschaweck NM; Ticku MK Drug Alcohol Depend; 2004 Sep; 75(3):323-5. PubMed ID: 15283953 [TBL] [Abstract][Full Text] [Related]
6. A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor. Castelli MP; Pibiri F; Carboni G; Piras AP CNS Drug Rev; 2004; 10(3):243-60. PubMed ID: 15492774 [TBL] [Abstract][Full Text] [Related]
7. Characterization and pharmacology of the GHB receptor. Ticku MK; Mehta AK Ann N Y Acad Sci; 2008 Oct; 1139():374-85. PubMed ID: 18991884 [TBL] [Abstract][Full Text] [Related]
8. Validation of high-affinity binding sites for succinic acid through distinguishable binding of gamma-hydroxybutyric acid receptor-specific NCS 382 antipodes. Molnár T; Visy J; Simon A; Moldvai I; Temesvári-Major E; Dörnyei G; Fekete EK; Kardos J Bioorg Med Chem Lett; 2008 Dec; 18(23):6290-2. PubMed ID: 18945616 [TBL] [Abstract][Full Text] [Related]
9. Binding characteristics of the gamma-hydroxybutyric acid receptor antagonist [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain. Mehta AK; Muschaweck NM; Maeda DY; Coop A; Ticku MK J Pharmacol Exp Ther; 2001 Dec; 299(3):1148-53. PubMed ID: 11714906 [TBL] [Abstract][Full Text] [Related]
10. Quantitative autoradiographic analysis of the new radioligand [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid ([(3)H]NCS-382) at gamma-hydroxybutyric acid (GHB) binding sites in rat brain. Gould GG; Mehta AK; Frazer A; Ticku MK Brain Res; 2003 Jul; 979(1-2):51-6. PubMed ID: 12850570 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and in vitro pharmacology of new radiolabeled gamma-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity gamma-hydroxybutyric acid binding sites. Sabbatini P; Wellendorph P; Høg S; Pedersen MH; Bräuner-Osborne H; Martiny L; Frølund B; Clausen RP J Med Chem; 2010 Sep; 53(17):6506-10. PubMed ID: 20715819 [TBL] [Abstract][Full Text] [Related]
12. New synthesis and tritium labeling of a selective ligand for studying high-affinity γ-hydroxybutyrate (GHB) binding sites. Vogensen SB; Marek A; Bay T; Wellendorph P; Kehler J; Bundgaard C; Frølund B; Pedersen MH; Clausen RP J Med Chem; 2013 Oct; 56(20):8201-5. PubMed ID: 24053696 [TBL] [Abstract][Full Text] [Related]
13. Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain. Castelli MP; Mocci I; Pistis M; Peis M; Berta D; Gelain A; Gessa GL; Cignarella G Eur J Pharmacol; 2002 Jun; 446(1-3):1-5. PubMed ID: 12098579 [TBL] [Abstract][Full Text] [Related]
14. Molecular Hybridization of Potent and Selective γ-Hydroxybutyric Acid (GHB) Ligands: Design, Synthesis, Binding Studies, and Molecular Modeling of Novel 3-Hydroxycyclopent-1-enecarboxylic Acid (HOCPCA) and trans-γ-Hydroxycrotonic Acid (T-HCA) Analogs. Krall J; Jensen CH; Bavo F; Falk-Petersen CB; Haugaard AS; Vogensen SB; Tian Y; Nittegaard-Nielsen M; Sigurdardóttir SB; Kehler J; Kongstad KT; Gloriam DE; Clausen RP; Harpsøe K; Wellendorph P; Frølund B J Med Chem; 2017 Nov; 60(21):9022-9039. PubMed ID: 29028338 [TBL] [Abstract][Full Text] [Related]
15. 3-chloropropanoic acid (UMB66): a ligand for the gamma-hydroxybutyric acid receptor lacking a 4-hydroxyl group. Macias AT; Hernandez RJ; Mehta AK; MacKerell AD; Ticku MK; Coop A Bioorg Med Chem; 2004 Apr; 12(7):1643-7. PubMed ID: 15028257 [TBL] [Abstract][Full Text] [Related]
16. GABA(B)-receptor mediation of the inhibitory effect of gamma-hydroxybutyric acid on intestinal motility in mice. Carai MA; Agabio R; Lobina C; Reali R; Vacca G; Colombo G; Gessa GL Life Sci; 2002 May; 70(25):3059-67. PubMed ID: 12138019 [TBL] [Abstract][Full Text] [Related]
17. A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand. Wu H; Zink N; Carter LP; Mehta AK; Hernandez RJ; Ticku MK; Lamb R; France CP; Coop A J Pharmacol Exp Ther; 2003 May; 305(2):675-9. PubMed ID: 12606613 [TBL] [Abstract][Full Text] [Related]
18. In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of γ-hydroxybutyrate (GHB) binding. Vogel KR; Ainslie GR; Roullet JB; McConnell A; Gibson KM Toxicol In Vitro; 2017 Apr; 40():196-202. PubMed ID: 28119166 [TBL] [Abstract][Full Text] [Related]
19. Succinate semialdehyde dehydrogenase deficiency does not down-regulate gamma-hydroxybutyric acid binding sites in the mouse brain. Mehta AK; Gould GG; Gupta M; Carter LP; Gibson KM; Ticku MK Mol Genet Metab; 2006 May; 88(1):86-9. PubMed ID: 16406647 [TBL] [Abstract][Full Text] [Related]
20. Positive allosteric modulation of the GHB high-affinity binding site by the GABAA receptor modulator monastrol and the flavonoid catechin. Eghorn LF; Hoestgaard-Jensen K; Kongstad KT; Bay T; Higgins D; Frølund B; Wellendorph P Eur J Pharmacol; 2014 Oct; 740():570-7. PubMed ID: 24973695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]